Atai life sciences to participate in the jefferies inaugural biotech cns/neuro summit

New york and berlin, oct. 06, 2023 (globe newswire) -- atai life sciences (nasdaq: atai) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the jefferies inaugural biotech cns/neuro summit being held from october 11-12, 2023.
ATAI Ratings Summary
ATAI Quant Ranking